Presently, Michael Schmertzler occupies the position of Chairman at PTC Therapeutics, Inc. Mr. Schmertzler is also on the board of Dispel LLC, The LOR Foundation, Inc., Berryville Holdings LLC and SHY Therapeutics LLC.

Mr. Schmertzler previously was Managing Director at Aries Advisors LLC, Chief Executive Officer & Director at Kolltan Pharmaceuticals, Inc., Managing Director & Chief Financial Officer at Lehman Brothers, Kuhn, Loeb, Inc., President for Morgan Stanley Leveraged Capital Fund, Inc., Senior Manager-Institutional Private Equity at Credit Suisse First Boston Equity Partners LP, Principal at Credit Suisse First Boston LLC, Head-International Investment Banking at Shearson Lehman Brothers, Inc. and Head-International Sales & Trading at Lehman Brothers, Inc.

Mr. Schmertzler received an undergraduate degree from Yale College and an MBA from Harvard Business School.